Workshop on acceleration of the validation and regulatory acceptance of alternative methods and implementation of testing strategies

Autor: Piersma, A H, Burgdorf, T, Louekari, K, Desprez, B, Taalman, R, Landsiedel, R, Barroso, J, Rogiers, V, Eskes, C, Oelgeschläger, M, Whelan, M, Braeuning, A, Vinggaard, A M, Kienhuis, A, van Benthem, J, Ezendam, J, Sub RIVM, dIRAS RA-1

Publikováno v: Piersma, A H, Burgdorf, T, Louekari, K, Desprez, B, Taalman, R, Landsiedel, R, Barroso, J, Rogiers, V, Eskes, C, Oelgeschläger, M, Whelan, M, Braeuning, A, Vinggaard, A M, Kienhuis, A, van Benthem, J & Ezendam, J 2018, ' Workshop on acceleration of the validation and regulatory acceptance of alternative methods and implementation of testing strategies ', Toxicology in Vitro, vol. 50, pp. 62-74 . https://doi.org/10.1016/j.tiv.2018.02.018
Toxicology in Vitro, 50, 62. NLM (Medline)

This report describes the proceedings of the BfR-RIVM workshop on validation of alternative methods which was held 23 and 24 March 2017 in Berlin, Germany. Stakeholders from governmental agencies, regulatory authorities, universities, industry and th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::045381594e3001d197f7f8ac98ab9db5
https://doi.org/10.1016/j.tiv.2018.02.018

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

State-of-the-art and new options to assess T cell activation by skin sensitizers: Cosmetics Europe Workshop

Autor: Del Bufalo A, Nichola Gellatly, Magalie Cluzel, Delrue N, Sebastian Hoffmann, Giese C, Takao Ashikaga, van Vliet E, Emanuela Corsini, Carsten Goebel, Silvia Martinozzi-Teissier, Jochen Kühnl, Desprez B, Marc Vocanson, Dirk Petersohn, Martina Klaric, Nathalie Alépée, Brunhilde Blömeke, Dean J. Naisbitt, Laura Gribaldo, Marc Pallardy, Maillere B

Publikováno v: ALTEX. 35(2)

Significant progress has been made in the development and validation of non-animal test methods for skin sensitization assessment. At present, three of the four key events of the Adverse Outcome Pathway (AOP) are assessable by OECD-accepted in vitro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e2c48a95c835f4cac0a58376bf640b7
https://pubmed.ncbi.nlm.nih.gov/28968481

Cosmetic Europe's long range science strategy – A non-animal safety assessment case study for phenoxyethanol, a cosmetic ingredient

Autor: Nepelska, M., Cronin, M.T.D., Cubberley, R., Dent, M., Firman, J.W., Fisher, J., Kenna, G., Mahony, C., Nicol, B., Piechota, S., Przybylak, K., Schepky, A., Tozer, S., Troutman, J., Desprez, B.

Publikováno v: In Toxicology Letters 10 October 2018 295 Supplement 1:S171-S171

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.